Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Federal Trade Commission
Harvard Business School
Queensland Health
Farmers Insurance
AstraZeneca
Express Scripts
Johnson and Johnson
UBS
Fuji

Generated: August 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021317

« Back to Dashboard
NDA 021317 describes BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN, which is a drug marketed by Bayer and is included in one NDA. Additional details are available on the BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN profile page.

The generic ingredient in BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN is aspirin. There are twenty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the aspirin profile page.

Summary for NDA: 021317

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength500MG
Approval Date:Oct 18, 2001TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Cerilliant
Federal Trade Commission
Chubb
AstraZeneca
Cipla
Cantor Fitzgerald
Harvard Business School
QuintilesIMS
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot